These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 7621247

  • 21. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
    Grant SL, Hammacher A, Douglas AM, Goss GA, Mansfield RK, Heath JK, Begley CG.
    Oncogene; 2002 Jan 17; 21(3):460-74. PubMed ID: 11821958
    [Abstract] [Full Text] [Related]

  • 22. Expression of the c-erbB-2 gene encoding a growth factor receptor.
    Yamamoto T, Akiyama T, Yokota J, Mori S, Toyoshima K.
    Princess Takamatsu Symp; 1986 Jan 17; 17():203-10. PubMed ID: 3455415
    [Abstract] [Full Text] [Related]

  • 23. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M, Noguchi K, Park YG, Lee YN, Cho-Chung YS.
    Clin Cancer Res; 2000 Sep 17; 6(9):3434-41. PubMed ID: 10999726
    [Abstract] [Full Text] [Related]

  • 24. c-erbB-2 anti-sense phosphorothioate oligodeoxynucleotides inhibit growth and serum-induced cell spreading of P185c-erbB-2-overexpressing ovarian carcinoma cells.
    Wiechen K, Dietel M.
    Int J Cancer; 1995 Nov 15; 63(4):604-8. PubMed ID: 7591273
    [Abstract] [Full Text] [Related]

  • 25. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D, Wolf JK, Scanlon M, Price JE, Hung MC.
    Cancer Res; 1993 Feb 15; 53(4):891-8. PubMed ID: 8094034
    [Abstract] [Full Text] [Related]

  • 26. Transcriptional regulation of the c-erbB-3 gene in human breast carcinoma cell lines.
    Skinner A, Hurst HC.
    Oncogene; 1993 Dec 15; 8(12):3393-401. PubMed ID: 8247542
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS.
    Clin Cancer Res; 2002 Feb 15; 8(2):607-14. PubMed ID: 11839683
    [Abstract] [Full Text] [Related]

  • 29. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME, Lupu R, Labriola L, Charreau EH, Elizalde PV.
    Oncogene; 1999 Nov 04; 18(46):6370-9. PubMed ID: 10597237
    [Abstract] [Full Text] [Related]

  • 30. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.
    Bos M, Mendelsohn J, Kim YM, Albanell J, Fry DW, Baselga J.
    Clin Cancer Res; 1997 Nov 04; 3(11):2099-106. PubMed ID: 9815602
    [Abstract] [Full Text] [Related]

  • 31. The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3.
    Alper O, Yamaguchi K, Hitomi J, Honda S, Matsushima T, Abe K.
    Cell Growth Differ; 1990 Dec 04; 1(12):591-9. PubMed ID: 1981143
    [Abstract] [Full Text] [Related]

  • 32. An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.
    Yokozaki H, Budillon A, Tortora G, Meissner S, Beaucage SL, Miki K, Cho-Chung YS.
    Cancer Res; 1993 Feb 15; 53(4):868-72. PubMed ID: 8428367
    [Abstract] [Full Text] [Related]

  • 33. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
    Aigner A, Juhl H, Malerczyk C, Tkybusch A, Benz CC, Czubayko F.
    Oncogene; 2001 Apr 19; 20(17):2101-11. PubMed ID: 11360194
    [Abstract] [Full Text] [Related]

  • 34. Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways.
    Niu G, Carter WB.
    Cancer Res; 2007 Feb 15; 67(4):1487-93. PubMed ID: 17308086
    [Abstract] [Full Text] [Related]

  • 35. Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines.
    Deshane J, Loechel F, Conry RM, Siegal GP, King CR, Curiel DT.
    Gene Ther; 1994 Sep 15; 1(5):332-7. PubMed ID: 7584099
    [Abstract] [Full Text] [Related]

  • 36. Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cells.
    Marth C, Müller-Holzner E, Greiter E, Cronauer MV, Zeimet AG, Doppler W, Eibl B, Hynes NE, Daxenbichler G.
    Cancer Res; 1990 Nov 01; 50(21):7037-41. PubMed ID: 2119884
    [Abstract] [Full Text] [Related]

  • 37. Regulation of expression and transforming ability of the c-erbB-2 gene.
    Matsuda S, Akiyama T, Yamada Y, Ishii S, Aizawa S, Mori S, Toyoshima K, Yamamoto T.
    Princess Takamatsu Symp; 1989 Nov 01; 20():93-101. PubMed ID: 2577338
    [Abstract] [Full Text] [Related]

  • 38. Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene products.
    Yan DH, Chang LS, Hung MC.
    Oncogene; 1991 Feb 01; 6(2):343-5. PubMed ID: 1672040
    [Abstract] [Full Text] [Related]

  • 39. c-erbB2 amplification and overexpression in human tumors.
    Lofts FJ, Gullick WJ.
    Cancer Treat Res; 1992 Feb 01; 61():161-79. PubMed ID: 1360230
    [Abstract] [Full Text] [Related]

  • 40. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon.
    D'Emilia J, Bulovas K, D'Ercole K, Wolf B, Steele G, Summerhayes IC.
    Oncogene; 1989 Oct 01; 4(10):1233-9. PubMed ID: 2571966
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.